Literature DB >> 28000288

The impact of kidney transplantation on insulin sensitivity.

Morten B Jørgensen1, Mads Hornum1, Gerrit van Hall2, Claus Bistrup3, Jesper M Hansen4, Elisabeth R Mathiesen5, Bo Feldt-Rasmussen1.   

Abstract

To investigate the impact of kidney transplantation (KTx) on insulin sensitivity affecting glucose metabolism. 9 nondiabetic patients awaiting living donor KTx were examined prior to transplantation with an oral glucose tolerance test and a 3-h hyperinsulinaemic-euglycaemic clamp. The clamp was repeated 6 months after KTx. Nine age-, gender- and body mass index (BMI)-matched individuals with normal kidney function served as controls. Endogenous glucose production and glucose disappearance rate (N = 6) were measured in a subgroup of patients with corresponding controls. Results presented as mean [range]. Two patients had pretransplant prediabetes, whereas all others had normal glucose tolerance. After KTx, average glucose infusion rate to maintain euglycaemia during clamp declined significantly from 15.1 [9.1-23.7] to 9.8 [2.8-14.6] μmol/kg/min (P < 0.01) with 20.2 [9.9-33.7] μmol/kg/min in controls. Endogenous glucose production increased from 7.0 [4.8-8.5] to 9.4 [7.4-11.8] μmol/kg/min (P < 0.05) with 7.0 [-3.8 to 10.1] μmol/kg/min in controls. Glucose disappearance rate was unchanged (18.1 [12.9-24.5] vs. 17.1 [12.2-22.7] μmol/kg/min, NS) with 22.3 [14.6-34.3] in controls. In conclusion, insulin sensitivity is reduced 6 months after KTx and characterized mainly by impaired suppression of the endogenous glucose production.
© 2016 Steunstichting ESOT.

Entities:  

Keywords:  hyperinsulinaemic-euglycaemic clamp; insulin resistance; kidney transplantation

Mesh:

Substances:

Year:  2017        PMID: 28000288     DOI: 10.1111/tri.12907

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  5 in total

Review 1.  Diabetes in Kidney Transplantation.

Authors:  Maria P Martinez Cantarin
Journal:  Adv Chronic Kidney Dis       Date:  2021-11       Impact factor: 3.620

Review 2.  Post-transplant diabetes mellitus in patients with solid organ transplants.

Authors:  Trond Jenssen; Anders Hartmann
Journal:  Nat Rev Endocrinol       Date:  2019-03       Impact factor: 43.330

3.  Successful use of the sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with renal transplant and diabetes: a case series and literature review.

Authors:  Wajiha Gul; Emad Naem; Safa Elawad; Tarik Elhadd
Journal:  Cardiovasc Endocrinol Metab       Date:  2021-03-17

4.  Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus?

Authors:  Quentin Faucher; Manon Jardou; Clarisse Brossier; Nicolas Picard; Pierre Marquet; Roland Lawson
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-07       Impact factor: 6.055

Review 5.  Current Pharmacological Intervention and Medical Management for Diabetic Kidney Transplant Recipients.

Authors:  Theerawut Klangjareonchai; Natsuki Eguchi; Ekamol Tantisattamo; Antoney J Ferrey; Uttam Reddy; Donald C Dafoe; Hirohito Ichii
Journal:  Pharmaceutics       Date:  2021-03-19       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.